Journal of Immunology Research / 2016 / Article / Tab 2

Research Article

Serum Levels of Soluble ST2 and IL-10 Are Associated with Disease Severity in Patients with IgA Nephropathy

Table 2

Effect of treatment on the values of clinical measures in follow-up IgAN patients.

 Before treatmentAfter treatment

Age, year46 (26–67)46 (26–67)
Female/male4/54/5
Lymphocytes, 109/L2.14 (1.24–3.65)1.78 (1.11–3.21)
Serum albumin, g/L29.7 (17.7–35.6)37.8 (25.8–48.2)
Serum uric acid, μmol/L385 (263–583)352 (231–516)
Triglycerides, mmol/L2.82 (1.24–5.46)2.55 (1.08–5.22)
Cholesterol, mmol/L6.22 (3.28–9.26)5.17 (2.11–7.13)
Urinary proteins, g/24 h4.41 (0.94–5.26)2.05 (0.38–3.32
Urea nitrogen, mmol/L5.71 (3.37–11.85)4.62 (2.65–9.38)
eGFR, mL/min/1.73 m278.36 (48.74–102.85)99.73 (60.26–118.38
Microscopic hematuria, rbc/hpf6.65 (1.35–21.12)2.04 (0.21–10.23
Serum calcium, mmol/L1.81 (1.64–2.33)2.37 (2.09–2.58
Serum phosphorus, mmol/L1.78 (1.03–2.08)1.13 (0.81–1.45
Serum IgA, g/L3.27 (1.56–4.63)1.82 (1.12–3.76

Data are present as median (range). versus values before treatment.